460. Disproportionalities in COVID-19 Clinical Drug Trials in the United States: A Systematic Literature Review
Poster Abstracts
[키워드] 2019-nCoV
African American
age
Arm
ARMS
calculated
Caucasian patient
clinical
clinical trial
clinical trials
Combination
Controlled trial
COVID-19
COVID-19 infection
COVID-19 patient
death
demographic
demographic characteristics
Descriptive statistics
drug
eligible
English language
enrolled
Ethnic groups
females
FIVE
for inclusion
Gender
Generalizability
Hospitalization
hospitalized patient
identify
limit
literature
literature review
male
median age
MOST
National
Older
participant
Participants
Patient
performed
pharmacologic treatment
placebo-controlled
race
Randomized controlled trial
reported
Result
review
Safe
SARS-CoV-2
study cohort
was performed
white
with COVID-19
[DOI] 10.1093/ofid/ofab466.659 PMC 바로가기 [Article Type] Poster Abstracts
[DOI] 10.1093/ofid/ofab466.659 PMC 바로가기 [Article Type] Poster Abstracts